← Leaderboards
Nancy Browning
The Emmes Company, Llc
$2,572,028
Attributed
$2,572,028
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $829.7K · FY2007–13$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,572,028 · 2
By mechanism
U01$1,510,186 · 1
R01$1,061,842 · 1
Top collaborators
No co-investigators on record.
Most similar at The Emmes Company, Llc
Same institution · by research overlap
- Ryan May$4,150,540
- Eve Jelstrom$42,013,348
- Paul Vanveldhuisen$63,018,753
- Paul Vanheldhuisen$5,463,397
Others in their field
Top investigators on “Lamotrigine”
- Tracy A Glauser · Children'S Hospital Med Ctr (Cincinnati)$23,477,503
- Kimford J Meador · Medical College Of Georgia (Mcg)$13,719,783
- Page Buckhannan Pennell · University Of Minnesota$9,936,244
- Ramin V Parsey · Columbia University Health Sciences$4,198,218
- Avital Cnaan · Children'S Hospital Of Philadelphia$4,013,355
- Angela K Birnbaum · University Of Minnesota$3,991,447
Research focus
LamotrigineProspectiveFutureInvestigationPerinatal ExposurePregnant WomenExposure ToFrequencies (Time Pattern)DesignIn UteroNeurobehavioralNeurodevelopmentDrug ExposurePregnancyCognitiveEpilepsyCohortFemale Of Child Bearing AgeAntiepileptic AgentsChildAffectGrantMothersSampling
Grant awards (4)
MONEAD Data and Statistical Center$680,451
U01 · FY2013 · NS · contact PI
MONEAD Data and Statistical Center$829,735
U01 · FY2012 · NS · contact PI
Neurodevelopment Effects of Antiepileptic Drugs$530,932
R01 · FY2008 · NS · contact PI
Neurodevelopment Effects of Antiepileptic Drugs$530,910
R01 · FY2007 · NS · contact PI